Consensus statement underscores need for device longevity after in-depth review of longevity performance data, product performance reports, risks associated with generator changes, economic impact of device longevity and manufacturer battery technology evolution.
Resources
All (-)
-
Longevity Proof Infographic
May 31, 2015
PDF( 626.0 KB )
EnduraLife Battery Technology Offers a Clinically Meaningful Difference in CRT-D Longevity
-
2013 Saba Trial
PDF( 364.0 KB )
This 6-year follow-up study shows divergence in battery longevity between Boston Scientific and St. Jude Medical beginning around year 5, with Boston Scientific having significantly higher device survival rate for CRT-D devices through year 6.
-
2014 Ellis Trial
PDF( 223.0 KB )
A multi-center, retrospective observational study with data collected from 710 patients showed that battery capacity (Ah) is a useful predictor of device longevity, and Boston Scientific devices, with a usable battery capacity of 2.0 Ah, last significantly longer than Medtronic or St. Jude Medical devices.
-
2014 Johansen Trial
PDF( 197.0 KB )
This independent, retrospective observational study comparing battery longevity of contemporary CRT-Ds of patients implanted with CRT-ICDs from January 1, 2007, to October 31, 2013, found that Boston Scientific CRT-Ds last significantly longer than Medtronic CRT-Ds.
-
2014 Williams Trial
PDF( 198.0 KB )
Explore the results of an independent, retrospective observational study comparing battery longevity of contemporary CRT-Ds. The results are from a non-academic community hospital (NCH), which may have substantial differences in age, gender and comorbidities than those in academic centers and national trials.
-
2015 Landolina Trial
PDF( 216.0 KB )
This independent, retrospective observational study comparing battery longevity of contemporary cardiac resynchronization therapy defibrillators (CRT-D) found that Boston Scientific’s modern CRT-Ds have the lowest risk of replacement at 5 years.
-
2015 Lau Trial
PDF( 208.0 KB )
See the results of this independent, retrospective observational study comparing battery longevity of contemporary cardiac resynchronization therapy defibrillators (CRT-Ds) of all patients implanted with CRT-ICDs from 2008 through 2009 at Royal Victoria Hospital in Belfast, Northern Ireland.
-
2016 Schaer/Von Gunten Trial
PDF( 353.0 KB )
The largest study to investigate multiple manufacturer ICD longevity to date, conducted with data from two large European centers, confirms Boston Scientific as the longevity leader across VR, DR and CRT ICDs.
-
-
Cardiac Rhythm Device Battery Life
PDF( 2.0 MB )
Novation Article from CV Watch Supplement, May 2012
-
-
Implantable Electronic Systems Product Performance Report 2016 First Edition
PDF( 56.0 MB )
Implantable Electronic Systems Product Performance Report 2016 First Edition
-
Longevity Risks and Needs Infographic
PDF( 635.0 KB )
Device replacement comes with risk. Discover why longer battery life gives defibrillator patients more.
STAY UP TO DATE
patients, payers and the healthcare system.
